Vindesine as a single agent and in combination with adriamycin in the treatment of metastatic breast carcinoma.
D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004317:Doxorubicin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D010292:Paresthesia / Q000139:chemically induced; D011897:Random Allocation; D014747:Vinblastine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use; D014751:Vindesine
D014750:Vincristine; D014747:Vinblastine; D004317:Doxorubicin; D014751:Vindesine